ILM1 Medios AG

11.50USD10.46 EUR · XETRA-1.13%Mkt Cap: 293.26M USDP/E: 29.89

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. …

Institutional holders10 on file

Key Statistics

Company
Market Cap293.26M USD
Enterprise Value396.29M USD
Revenue (TTM)2.40B USD
Gross Profit218.93M USD
Net Income (TTM)16.89M USD
Revenue/Share97.83 USD
Last Price11.50 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees960
CountryDE
SectorHealthcare
IndustryMedical Distribution
ISINDE000A1MMCC8
Valuation
P/E (Trailing)29.89
P/E (Forward)6.18
PEG—
EV/EBITDA5.15
EV/Revenue0.17
P/S0.12
P/B0.49
EPS (TTM)0.38 USD
EPS (Forward)1.86 USD
52W Range
10.976% of range19.17
52W High19.17 USD
52W Low10.97 USD
Profitability
Gross Margin9.58%
Oper. Margin1.68%
EBITDA Margin3.21%
Profit Margin0.74%
ROE2.99%
ROA1.70%
ROIC3.76%
ROCE5.88%
Growth
Revenue Growth3.70%
Earnings Growth-41.60%
Cash Flow & Leverage
Operating CF57.46M USD
CapEx (TTM)9.11M USD
FCF Margin0.46%
FCF Yield3.74%
Net Debt114.38M USD
Net Debt/EBITDA1.49
Net Debt/FCF10.42
Balance Sheet
Debt/Equity0.37
Current Ratio1.67
Quick Ratio1.18
Book Value/Sh23.67 USD
Cash/Share4.21 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJul 19, 2012
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.57 USD
Upside (mean)+87.6%
Target Range16.49 USD – 25.28 USD
16.49+87.6% to mean25.28
# Analysts4
Ownership
Shares Out.25.51M
Float14.33M
Insiders19.70%
Institutions46.88%
Technical
SMA 5011.63 (-1.2%)
SMA 20013.61 (-15.5%)
Beta1.34
S&P 52W Chg8.68%
Avg Vol (30d)49.98K
Avg Vol (10d)70.53K
Technical Indicators
RSI (14)44.9
MACD-0.0238
MACD Signal0.0676
MACD Hist.-0.0914
BB Upper12.93 USD
BB Middle11.92 USD
BB Lower10.91 USD
BB Width16.90%
ATR (14)0.5160 USD
Vol Ratio (20d)1.25x

About Medios (ETR: ILM1)

›

Medios (ETR: ILM1) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 960 employees.

The shares were at 10.46 EUR on 20 November 2026, down 25.1% over 52 weeks. Its 52-week range is 9.980 EUR to 17.44 EUR: the price is 40.0% below the high and 4.8% above the low.

At a market capitalisation of 266.79M EUR, it trades at 29.9 times trailing earnings and 6.2 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 19.9, a premium of 50% for ILM1.

Medios reports return on equity of 3.0%, an operating margin of 1.7% and revenue up 3.7% year over year.

Its debt exceeds its cash by 104.06M EUR, a debt-to-equity ratio of 0.37. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 4 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 19.63 EUR is 87.6% above the current price. The next earnings report is expected on 25 March 2027.